Promoter hypermethylation of O6 methylguanine-DNA methyltransferase gene in cholangiocarcinoma

Journal of Chinese Clinical Medicine

Volumn 5, Issue 8, 2010, Pages 463-468

  Liu, Xiao Fang ^a   Sun, Xian Chun ^a   Zhang, Cui Sheng ^a   Xu, Zheng ^a   Li, Shao Jun ^a   Zhou, Xian Ting ^a   Sun, Shi Jie ^a  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Cholangiocarcinoma; Hypermethylation; Methylation specific PCR; O6methylguanine DNA methyltransferase gene

Indexed keywords

BISULFITE; CYTOSINE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; URACIL;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BILE DUCT CARCINOMA; CANCER INVASION; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DNA MODIFICATION; FEMALE; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MALE; POLYMERASE CHAIN REACTION; PREDICTION; PROGNOSIS; PROMOTER REGION; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION;

EID: 78049471312     PISSN: 15629023     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Guza R, Ma L, Fang Q, Pegg AE, Tretyakova N. Cytosine methylation effects on the repair of 06methylguanines within CG dinucleoti- des.J Biol Chem, 2009,284:22601-22610.
2. Kulke MH, Hornick JL, Frauenhoffer C, Hooshmand S, Ryan DP, Enzinger PC, et al. 06methylguanine DNA methyltransferase deficiency and response to temozolomide-based therapy in patients with neuroendocrine tumors. Clin Cancer Res,2009,15:338-345.
3. Everhard S, Tost J, El Abdalaoui H, Crinière E, Busato F, Marie Y, et al. Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomas. Neuro Oncol, 2009, 11: 348-356.
4. Hiraga J, Kinoshita T, Ohno T, Mori N, Ohashi H, Fukami S, et al. Promoter Hypermethylation of the DNARepair Gene 06-Methylguanine DNA Methyl-transferase and p53 Mutation in Diffuse Large BCell Lymphoma. Int J Hematol,2006,84:248-255.
5. Liu XF, Zhu SG, Zhang H, Xu Z, Su HL, Li SJ, et al. The methylation status of the TMS1ASC gene in cholangiocarcinoma and its clinical significance. Hepatobiliary Pancreat Dis Int,2006,5:449453.
6. Ohtsuka T,Liu XF,Koga Y,Kitajima Y,Nakafusa Y, Ha CW,et al. Methylation-induced silencing of ASC and the effect of expressed ASC on p53mediated chem-osensitivity in colorectal cancer. Oncogene 2006;25:1807-1811.PMID: 16331272
7. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarci-noma. Lancet,2005,366:1303-1314.
8. Liu XF, Zhou XT, Zou SQ. An analysis of 680 cases of cholangiocarcinoma from 8 hospitals. Hepatobiliary Pancreat Dis Int, 2005,4: 585-588.
9. Zhai R, Qian X, Dai D, Yu P. Malignant biliary obstruction: treatment with interventional radiology. Chin Med J, 2003,116(6):888-892.
10. Reddy SB, Patel T. Current approaches to the diagnosis and treatment of cholangiocarcinoma. Curr Gastroenterol Rep,2006,8(1);30-37.
11. Christmann M, Kaina B. Nuclear translocation of mismatch repair proteins MSH2 and MSH6 as a response of cells to alkylating agents. J Biol Chem,2000,17:36256-36262.
12. Kreklau EL, Limp-Foster M, Liu N, Xu Y, Kelley MR, Erickson LC. A novel fluorometric oligonucleotide assay to measure 0(6) methylguanine DNA methyltransferase, methylpurine DNA glycosy-lase, 8-oxoguanine DNA glycosylase and abasic endonuclease activities: DNA repair status in human breast carcinoma cells overexpress-ing methylpurine DNA glycosylase. Nucleic Acids Res, 2001, 15: 2558-2566.
13. Soejima H,Zhao W,Mukai T. Epigenetic silencing of the MGMT gene in cancer. Biochem Cell Biol,2005,83:429-437.
14. Esteller M. Aberrant DNA methylation as a cancer-inducing mechanism. Annu Rev Pharmacol Toxicol, 2005,45:629-656.
15. Ahlquist T, Lind GE, Costa VL, Meling GI, Vatn M, Hoff GS, et al. Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers. Mol Cancer, 2008,7:94.
16. Lind GE, Thorstensen L, Lovig T, Meling GI, Hamelin R, Rognum TO,et al. A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines. Mol Cancer 2004,11:28.
17. Lee S, Hwang KS, Lee HJ, Kim JS, Kang GH. Aberrant CpG island hyperme-thylation ol multiple genes in colorectal neoplasia. Lab Invest.,2004,84:884-893.
18. Mamya S, Issa JP, Weber RS, Rosenthal DI, Haviland JC, Lotan R,et al. Differential methylation status ol tumor-associated genes in head and neck squamous carcinoma: incidence and potential implications. Clin Cancer Res, 2004,1:3825-3830.
19. Uccella S, Cerutti R,Placidi C, Marchet S,Camevali I, Bernasconi B, et al. MGMT methylation in diffuse large B-cell lymphoma: validation of quantitative methylation-specific PCR and comparison with MGMT protein expression. J Clin Pathol,2009,62:715-723.
20. 6methylguanine-DNA methyltranslerase combined with mismatch-repair proteins hMLHl and hMSH2 is related to poor prognosis in human biliary tract carci noma. Ann Surg Oncol, 2002,9:371-379.
21. 6methylguanine DNA methyltranslerase by promoter CpG island hypermethylation in gastric cancers. Br J Cancer,2002,86:1888-1892.
22. Munot K, Bell SM, Lane S, Horgan K, Hanby AM, Speirs V. Pattern of expression ol genes linked to epigenetic silencing in human breast cancer. Hum Pathol, 2006,37:989-999.